Latest News
Europe midday: Shares dip despite possibility Parliament may bin 'no deal' option
Stocks on the Continent are trading slightly lower as investors wait on a key speech by the head of the US central bank, despite apparent progress in avoiding a so-called 'no deal' Brexit.
2018 worst year for returns for a decade, research shows
Last year was the worst for returns from global equities since the financial crisis, according to research published by Credit Suisse.
Cora Gold posts decent drilling results from Sanankoro
West Africa-focussed gold exploration company Cora Gold provided initial results from its recently-completed aircore (AC) and reverse circulation (RC) drill programme at the Sanankoro Gold Discovery in the Yanfolila Gold Belt, Southern Mali on Tuesday, where it said the focus had been outlining higher grade areas.
Amur shares surge on publication of Kun-Manie study
Russia-focussed nickel-copper sulphide exploration and development company Amur Minerals released its pre-feasibility study (PFS) on its Kun-Manie nickel-copper sulphide project on Tuesday.
TMT invests $2m into education-focussed MEL Science
Technology venture capital company TMT Investments announced an investment of $2m in MEL Science as part of a wider funding round on Tuesday.
US pre-open: Stocks seen lower as investors eye Powell testimony
US stocks looked set for a weaker open on Tuesday as optimism over Sino-US trade relations faded and investors eyed Federal Reserve chairman Jerome Powell's testimony before the US Senate.
US regulator asks judge to hold Elon Musk in contempt over deal
The US Securities and Exchange Commission has requested that Tesla boss Elon Musk be held in contempt for violating a deal with the regulator as he once again tweeted false information about the company.
ImmuPharma upbeat on product from subsidiary Ureka
Specialist drug discovery and development company ImmuPharma announced on Tuesday that on 25 February, the peer reviewed research journal Nature Communications published a fundamental scientific publication on the proprietary technology ‘Urelix’ from its subsidiary Ureka.
London midday: Stocks wallow as pound surges; Ocado flies on M&S tie-up
London stocks were still firmly in the red by midday on Tuesday, dragged lower by a stronger pound as investors grew increasingly hopeful that a 'no deal' Brexit can be avoided.
Syncona pours £21m into immuno-oncology company Anaveon
Syncona announced a CHF 28m (£21. 4m) commitment to Anaveon, a new immuno-oncology company, in a CHF 35m Series A financing on Tuesday, alongside the Novartis Venture Fund.
Drax earnings rise as it looks for further investment opportunities
Drax Group announced a 9% improvement in group adjusted EBITDA in its full-year results on Tuesday, to £250m, which it said was a result of continued strength in its cash generation and balance sheet.
N Brown appoints Steve Johnson as CEO
Online retailer N Brown has appointed interim chief executive officer Steve Johnson to the position on a permanent basis with immediate effect.
Tlou Energy aims for 'further significant advancements'
Africa-focussed coal bed methane developer Tlou Energy believes itself to be well positioned to make "further significant advancements" after slightly narrowing losses in the first half of its trading year.
UK mortgage approvals edge higher
The number of new mortgages approved by the main high street lenders nudged upwards in January, data published on Tuesday showed.
Jardine Lloyd profits rise 25%
Jardine Lloyd Thompson, which has recommended an offer from Marsh & McLennan, revealed that it grew profits 25% last year.
CMA to investigate NSF's £1.3bn bid for Provident Financial
The Competition and Markets Authority said on Tuesday that it will investigate Non-Standard Finance's £1. 3bn takeover bid for larger rival Provident Financial.
Derwent shrugs off Brexit jitters as net asset value nudges ahead
Derwent London unveiled an improvement in net asset value and full-year earnings on Tuesday, as it announced it had appointed a contractor for Soho Place, its flagship development above Tottenham Court Road tube station.
Hotel Chocolat takes encouragement from US and Japan launches
Hotel Chocolat on Tuesday reported interim revenue and profit growth after strong digital sales and very encouraging initial progress from its international expansion in Japan and the United States.
SigmaRoc inks licence for UK roll-out of Road Zipper
Construction materials provider SigmaRoc has signed up for an exclusive license to offer the Road Zipper system in the UK.
AstraZeneca's Lynparza shows positive results in pancreatic cancer trial
AstraZeneca has reported positive results from a phase 3 trial of the Lynparza drug, which met the primary endpoint in a study for metastatic pancreatic cancer.